0001382963-18-000009.txt : 20180125 0001382963-18-000009.hdr.sgml : 20180125 20180125210010 ACCESSION NUMBER: 0001382963-18-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180123 FILED AS OF DATE: 20180125 DATE AS OF CHANGE: 20180125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ritter Ira E. CENTRAL INDEX KEY: 0001631674 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 18549713 MAIL ADDRESS: STREET 1: C/O RITTER PHARMACEUTICALS INC. STREET 2: 1801 CENTURY PARK EAST, SUITE 1820 CITY: LOS ANGELES STATE: CA ZIP: 90096 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 310-203-1000 MAIL ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-01-23 0001460702 RITTER PHARMACEUTICALS INC RTTR 0001631674 Ritter Ira E. RITTER PHARMACEUTICALS, INC. 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 1 1 0 0 Exec. Chairman, CSO Non-Qualified Stock Option (Right to Buy) .34 2018-01-23 4 A 0 495065 0 A 2028-01-23 Common Stock 495065 495065 D The option vests in forty-eight (48) equal monthly installments beginning on February 23, 2018 with the balance vesting on the 23rd day of each calendar month thereafter until vested in full. /s/Andrew J. Ritter, attorney-in-fact 2018-01-25